ITOCO Inc. (OTC PINK:ITMC) announces the appointment of Hadelin Carlos Diericx Trouyet to its Board of Directors. Mr. Diericx brings over 25 years of experience as a serial entrepreneur, with significant expertise in business development across Mexico, the U.S., and Latin America. He has been involved in initiatives such as the Nopal Cactus Carbon Capture Program, promoting sustainability in agriculture. ITOCO aims to lead in biotech technologies and methodologies, emphasizing environmentally friendly practices.
ITOCO INC. (OTC Pink: ITMC) has announced the appointment of Santiago Pablo Obarrio as VP Latin America and member of the Board of Directors. With over 25 years of experience in sustainable real estate development across various countries, Obarrio's background includes projects in Argentina, the Bahamas, and South America. He co-founded notable organizations in the Blue Economy and has directed several ventures in diverse sectors, indicating a strategic focus on innovative, regenerative projects. This leadership change aims to enhance ITOCO’s presence in Latin America.
ITOCO INC. (OTC PINK:ITMC) has appointed Mr. Jamie Sanchez Cortina as Chief Operating Officer and member of the Board of Directors. A founding member of ECAFIN, recently acquired by ITOCO, he has extensive experience in managing venture capital portfolios and strategic development. Cortina previously managed over US$170 million at the Abraaj Group and played key roles in various venture capital initiatives in Mexico. ITOCO continues to focus on developing environmentally-friendly biotech solutions.
ITOCO INC. (OTC PINK:ITMC) has announced a purchase agreement to acquire assets from ECAPFIN S.A.P.I. De C.V. based in Mexico City. The assets include Bio Tech related to the Nopal Cactus, agreements for commercial product development, and technical knowledge for applying for Carbon Credits. The acquisition aims to leverage the Nopal plant's properties in creating environmentally friendly products. Due diligence will be conducted with a transaction close expected by June 30, 2021. CEO Michael Paul expressed optimism about the potential of ECAPFIN's technology.
ITOCO INC. (OTC PINK: ITMC) plans to launch a mobile application for Immutable Virus Test Result Verification. This application enables users to securely prove their virus screening results through blockchain technology, facilitating safe return to business for employers and public entities. It features a biometric reader for digital identity verification and integrates with testing systems for real-time result updates. The CEO, Greg Marlin, emphasizes the importance of this technology for commercial utilization, and discussions for integration with rapid testing technologies are underway.
ITOCO INC. (OTC Pink: ITMC) has launched a secure SaaS web application at ImmutableTest.com for the Immutable Virus Test Result Verification System. This deployment follows their blockchain smart contract initiative, marking significant advancement in commercializing their patent-pending technology. The application allows System Administrators to manage anonymized users and whitelisted virus testing systems. Future developments include a user-facing mobile application utilizing blockchain and biometric technologies. CEO Michael Paul emphasized the commitment to commercializing their technology portfolio.
ITOCO INC. (OTC PINK:ITMC) has announced the successful deployment of its blockchain technology for the patent-pending Immutable Virus Test Result Verification System on the Ethereum Ropsten test network. This milestone marks a critical step in commercializing the technology, aimed at supporting sectors like casinos, airlines, and live events, which have been heavily impacted by the pandemic. Key benefits include enhanced operational safety and transparency for customers and staff. The next phase involves developing administration software, with updates expected soon.
ITOCO INC. (OTC PINK:ITMC) has acquired patent-pending technology for Immutable Virus Test Result Verification from DATANet Software Development Corp. This system will enable users to prove their virus negative status and vaccine records by creating a biometrically registered digital record on the blockchain. The new system aims to facilitate faster and safer reopening of industries impacted by the pandemic, allowing users to easily verify their health status for public events and travel. This acquisition underscores ITOCO's commitment to building its intellectual property portfolio in the bio-tech sector.